Cynthia D. Brown

2.4k total citations · 1 hit paper
43 papers, 1.3k citations indexed

About

Cynthia D. Brown is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Cynthia D. Brown has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Cynthia D. Brown's work include Cystic Fibrosis Research Advances (16 papers), Respiratory Support and Mechanisms (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Cynthia D. Brown is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Respiratory Support and Mechanisms (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Cynthia D. Brown collaborates with scholars based in United States, United Kingdom and Australia. Cynthia D. Brown's co-authors include Robert A. Wise, Douglas C McCrory, Peter B. Bach, James F. Donohue, Christopher E. Cox, Marc A. Judson, Yash P. Kataria, K Nakamura, Thomas F. Budinger and Dale A. Schoeller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Cynthia D. Brown

38 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

2023 82 citations Steven M. Rowe, Jonathan B. Zuckerman et al. Journal of Cystic Fibrosis profile →

Peers

Countries citing papers authored by Cynthia D. Brown

Since Specialization

Citations

This map shows the geographic impact of Cynthia D. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia D. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia D. Brown more than expected).

Fields of papers citing papers by Cynthia D. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia D. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia D. Brown. The network helps show where Cynthia D. Brown may publish in the future.

Co-authorship network of co-authors of Cynthia D. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia D. Brown. A scholar is included among the top collaborators of Cynthia D. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia D. Brown. Cynthia D. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline Characteristics and Self‐Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO‐2) Cohort 2025 ·Pediatric Pulmonology ·(unknown), Kevin J. Psoter, Cynthia D. Brown, Josh Ostrenga, (unknown), (unknown), Bradley H. Rosen, (unknown), (unknown), Kathryn A. Sabadosa, Clement L. Ren	1
2	Gender Differences in Mental Well‐Being Among Children and Adults With Cystic Fibrosis in the Modulator Era 2025 ·Pediatric Pulmonology ·Anna M. Georgiopoulos, Aricca D. Van Citters, Cynthia D. Brown, (unknown), (unknown), (unknown), (unknown), Traci M. Kazmerski	0
3	Physical well-being and burden of care in adults on modulator therapy: A mixed methods study of patient-reported experiences from the Well-ME survey 2025 ·Journal of Cystic Fibrosis ·Cynthia D. Brown, (unknown), Elizabeth L. Yu, (unknown), (unknown), Aricca D. Van Citters	0
4	The Impact of Personal-Level Social Networks on Treatment Adherence, Depression, Anxiety, and Perceived Stigma Among Adults with Cystic Fibrosis: An Egocentric Network Analysis 2025 ·International Journal of Behavioral Medicine ·(unknown), Heather Francis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Janice Wang, Cynthia D. Brown, Erin Pullen, (unknown)	1
5	Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis 2024 ·Journal of Cystic Fibrosis ·Aricca D. Van Citters, (unknown), Jessica A. Alvarez, Cynthia D. Brown, (unknown), (unknown), (unknown), Anna M. Georgiopoulos, Christopher H. Goss, Traci M. Kazmerski, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	9
6	Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis 2024 ·Pediatric Pulmonology ·Rebecca S. Pettit, (unknown), Kerry A. Kinney, Cynthia D. Brown, (unknown), Sarah Wagner, Emma M. Tillman	0
7	Recombinant Alpha-1 Antitrypsin–Fc Fusion Protein INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study 2024 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Mark Brantly, Brooks Kuhn, (unknown), Ravi Mahadeva, (unknown), Catherina L. Chang, Cynthia D. Brown, Michael Campos, Jorge Lascano, (unknown), (unknown), (unknown), (unknown), (unknown), James Kalabus, Brendan P. Eckelman, (unknown)	5
8	Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis 2024 ·SHILAP Revista de lepidopterología ·Bradley H. Rosen, Kevin J. Psoter, Kathryn A. Sabadosa, (unknown), (unknown), (unknown), (unknown), Clement L. Ren, Cynthia D. Brown	3
9	Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study breakdown → 2023 ·Journal of Cystic Fibrosis ·Steven M. Rowe, Jonathan B. Zuckerman, Daniel Dorgan, Jorge Lascano, Karen McCoy, Manu Jain, Michael S. Schechter, (unknown), (unknown), Noah Lechtzin, Kimberly McBennett, (unknown), Cynthia D. Brown, Theodore G. Liou, Kelvin D. MacDonald, Samya Z. Nasr, (unknown), (unknown), Eric B. Meltzer, Ann Barbier	82
10	Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor 2023 ·International Journal of Neonatal Screening ·(unknown), (unknown), Cynthia D. Brown, Melissa Wesson, (unknown), James E. Slaven, James F. Chmiel, Raksha Jain, Don B. Sanders	10
11	Multicenter Validation of a Customizable Scoring Tool for Selection of Trainees for a Residency or Fellowship Program. The EAST-IST Study 2017 ·Annals of the American Thoracic Society ·Gabriel T. Bosslet, W. Graham Carlos, David J. Tybor, Jennifer W. McCallister, (unknown), Ashley G. Henderson, Matthew Miles, Homer L. Twigg, Catherine R. Sears, Cynthia D. Brown, Mark O. Farber, (unknown), John D. Buckley	3
12	CHRONIC OPIOID USE IS ASSOCIATED WITH SIGNIFICANT HIGHER 12-MONTH ALL-CAUSE READMISSION AND ALL-CAUSE MORTALITY BUT NOT ASSOCIATED WITH 30-DAY ALL-CAUSE READMISSION OR ALL-CAUSE MORTALITY IN OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE 2016 ·Journal of the American College of Cardiology ·(unknown), Sarah J. Goodlin, Wen‐Chih Wu, Charity J. Morgan, Sijian Zhang, (unknown), Marc R. Blackman, Ross D. Fletcher, Cynthia D. Brown, Gregg C. Fonarow, Prakash Deedwania, Wilbert S. Aronow, Ioannis Kanonidis, Richard M. Allman, Ali Ahmed	1
13	Intragenic CFTR Duplication and 5T/12TG Variant in a Patient with Non-Classic Cystic Fibrosis 2016 ·Scientific Reports ·Patrícia B. S. Celestino-Soper, Edward Simpson, (unknown), (unknown), Stephen R. Dlouhy, Matteo Vatta, (unknown), Cynthia D. Brown, Shaochun Bai	3
14	Effects of Sleep Apnea on Nocturnal Free Fatty Acids in Subjects with Heart Failure 2011 ·SLEEP ·Jonathan C. Jun, Luciano F. Drager, Samer S. Najjar, Stephen S. Gottlieb, Cynthia D. Brown, Philip L. Smith, Alan R. Schwartz, Vsevolod Y. Polotsky	51
15	Exercise Testing in Severe Emphysema: Association with Quality of Life and Lung Function 2008 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Cynthia D. Brown, Joshua O. Benditt, Frank C. Sciurba, Shing M. Lee, Gerard J. Criner, Zab Mosenifar, David Shade, William A. Slivka, Robert A. Wise	46
16	Field Tests of Exercise in COPD: The Six-Minute Walk Test and the Shuttle Walk Test 2007 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Cynthia D. Brown, Robert A. Wise	43
17	Exogenous Lipoid Pneumonia Secondary to an Occupational Exposure in a Furntiture Factory 2004 ·CHEST Journal ·Cynthia D. Brown, (unknown), (unknown), (unknown)	1
18	Lemierre's variant 2004 ·The Lancet Infectious Diseases ·Justin E. Bekelman, John S. Francis, (unknown), (unknown), Cynthia D. Brown	1
19	The Sarcoidosis Health Questionnaire 2003 ·American Journal of Respiratory and Critical Care Medicine ·Christopher E. Cox, James F. Donohue, Cynthia D. Brown, Yash P. Kataria, Marc A. Judson	94
20	Management of Acute Exacerbations of COPD 2001 ·CHEST Journal ·Douglas C McCrory, Cynthia D. Brown, (unknown), Peter B. Bach	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact